Table 3 |
|||
|
Age, sex and time since transplantation distribution in HPV seropositives compared to seronegatives among Caucasian transplant patients without skin cancer from London and Oxford (N = 425) |
|||
|
Seronegative to all HPV types |
Seropositive to at least one HPV type |
total |
|
|
N = 59 |
N = 366 |
N = 425 |
|
|
|
|||
|
Sex |
|||
|
male |
25 (42) |
140 (38) |
165 (39) |
|
female |
34 (58) |
226 (62) |
260 (61) |
|
P-het. |
0.5 |
||
|
age at recruitment |
|||
|
<45 |
24 (41) |
163 (45) |
187 (44) |
|
45 to 59 |
20 (34) |
138 (38) |
158 (37) |
|
≥ 60 |
15 (25) |
65 (18) |
80 (19) |
|
P-trend |
0.3 |
||
|
time since transplantation |
|||
|
<5 |
24 (41) |
126 (34) |
150 (35) |
|
5 to 9 |
11 (19) |
102 (28) |
113 (27) |
|
≥ 10 |
24 (41) |
138 (38) |
162 (38) |
|
P-trend |
1.0 |
||
|
|
|||
|
N: number; HPV: Human papillomavirus; het: heterogeneity. P-value using conditional (on centre) logistic regression adjusted for each others. |
|||
|
Casabonne et al. Infectious Agents and Cancer 2009 4:13 doi:10.1186/1750-9378-4-13 |
|||